ANAVEX LIFE SCIENCES CORP. Income Tax Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Income Tax Expense of $18.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- ANAVEX LIFE SCIENCES CORP. income tax expense (benefit) for the quarter ending 2025-12-31 was $18.00K.
- ANAVEX LIFE SCIENCES CORP. income tax expense (benefit) for the quarter ending 2016-06-30 was $6.00K.
- ANAVEX LIFE SCIENCES CORP. income tax expense (benefit) for fiscal 2014 was -$1.40M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-28 | $0.00 derived: sum of 2 quarters · filed 2026-08-28 | $18.00K 10-Q · filed 2026-08-28 | |
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-28 | $18.00K 10-Q · filed 2026-08-28 | ||
| 2025-12-31 | $18.00K 10-Q · filed 2026-02-09 | |||
| 2016-06-30 | $6.00K 10-Q · filed 2016-08-11 | $6.00K derived: sum of 2 quarters · filed 2016-08-11 | $23.61K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | $17.61K 10-Q · filed 2016-05-11 | ||
| 2015-12-31 | $17.61K 10-Q · filed 2016-02-08 | |||
| 2014-09-30 | -$1.40M 10-K · filed 2015-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |